Publications by authors named "Muriel Tania Go"
Purpose: Describe fracture risk assessment practices among physicians treating osteoporosis in a real-life setting.
Methods: This is a retrospective cohort study in a tertiary academic center. Inclusion criteria involved adults (aged ≥18 years) who received minimum adequate therapy (bisphosphates, raloxifene, or denosumab ≥ 3 years or teriparatide ≥ 18 months).
Objective: The commonly held association of hyperthyroidism with sinus tachycardia and widened pulse pressure (PP) has not been reassessed in decades despite patients with hyperthyroidism in current practice not always present with these signs. The study objective was to assess prevalence and variability of sinus tachycardia and widened PP in present day among individuals with different degrees of hyperthyroidism.
Methods: Data was collected retrospectively from 248 adult patients in an outpatient setting with biochemical evidence of hyperthyroidism, recorded heart rate (HR) and blood pressure (BP) who were not treated with medications that can influence these parameters.
Article Synopsis
- The study aimed to analyze physicians' treatment preferences and patterns for osteoporosis therapy over a 10-year period, focusing on various medications.
- A total of 12,885 patients were identified, with 274 meeting the inclusion criteria; the majority were women with a mean age of 68.8 years, primarily treated by primary care physicians and rheumatologists.
- Alendronate was found to be the most frequently prescribed initial therapy, while denosumab was the most common second treatment after a drug holiday.